The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza

References

• Stohr K. Preventing and treating influenza. Br Med J 2003; 326: 1223–4
   PubMed Web of Science ®Google Scholar
• Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solorzano A, Swayne DE, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005; 310: 77–80
   PubMed Web of Science ®Google Scholar
• Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351: 467–71
   PubMed Web of Science ®Google Scholar
• Mote, JR. Human and swine influenzas. Virus and rickettsial diseases. CambridgeMassachusetts: Harvard University Press; 1940. p. 429–516.
   Google Scholar
• McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006; 19: 571–82
   PubMed Web of Science ®Google Scholar
• Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine 1999; 17(Suppl 1)S3–10
   PubMed Web of Science ®Google Scholar
• Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179–86
   PubMed Web of Science ®Google Scholar
• Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005; 165: 265–72
   PubMed Web of Science ®Google Scholar
• Harford CG, Leidler V, Hara M. Effect of the lesion due to influenza virus on the resistance of mice to inhaled pneumococci. J Exp Med 1949; 89: 53–67
   PubMed Web of Science ®Google Scholar
• Plotkowski MC, Puchelle E, Beck G, Jacquot J, Hannoun C. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. Am Rev Respir Dis 1986; 134: 1040–4
   PubMed Web of Science ®Google Scholar
• Stone WJ, Swift GW. Influenza and influenzal pneumonia at Fort Riley, Kansas. JAMA 1919; 72: 487–93
   Google Scholar
• Wilson CB, Steer P. Bacteriological and pathological observations on influenza as seen in France during 1918. Br Med J 1919; 1: 634–5
   Google Scholar
• Louria D, Blumenfeld H, Ellis J, Kilbourne ED, Rogers D. Studies on influenza in the pandemic of 1957–1958. II. Pulmonary complications of influenza. J Clin Invest 1959; 38: 213–65
   PubMed Web of Science ®Google Scholar
• Martin CM, Kunin CM, Gottlieb LS, Barnes MW, Liu C, Finland M. Asian influenza A in Boston, 1957–1958. I. Observations in 32 influenza-associated fatal cases. AMA Arch Intern Med 1959; 103: 515–31
   PubMedGoogle Scholar
• McCullers JA, Webster RG. A mouse model of dual infection with influenza virus and Streptococcus pneumoniae. Options for the Control of Influenza IV, ADME Osterhaus, N Cox, AW Hampson. Elsevier Science B.V, Amsterdam 2001; 601–7
   Google Scholar
• McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 2002; 186: 341–50
   PubMed Web of Science ®Google Scholar
• McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis 2003; 187: 1000–9
   PubMed Web of Science ®Google Scholar
• Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I, Tuomanen EI. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995; 377: 435–8
   PubMed Web of Science ®Google Scholar
• Radin JN, Orihuela CJ, Murti G, Guglielmo C, Murray PJ, Tuomanen EI. Beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae. Infect Immun 2005; 73: 7827–35
   PubMed Web of Science ®Google Scholar
• Smith MW, Schmidt JE, Rehg JE, Orihuela C, McCullers JA. Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia following influenza. Comp Med 2007; 57: 12–8
   Web of Science ®Google Scholar
• Peltola VT, Murti KG, McCullers JA. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis 2005; 192: 249–57
   PubMed Web of Science ®Google Scholar
• Swords WE, Buscher BA, Ver SI, Preston A, Nichols WA, Weiser JN, et al. Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol 2000; 37: 13–27
   PubMed Web of Science ®Google Scholar
• Soares AC, Pinho VS, Souza DG, Shimizu T, Ishii S, Nicoli JR, et al. Role of the platelet-activating factor (PAF) receptor during pulmonary infection with Gram- negative bacteria. Br J Pharmacol 2002; 137: 621–8
   PubMed Web of Science ®Google Scholar
• Ring A, Weiser JN, Tuomanen EI. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest 1998; 102: 347–60
   PubMed Web of Science ®Google Scholar
• Rijneveld AW, Weijer S, Florquin S, Speelman P, Shimizu T, Ishii S, et al. Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J Infect Dis 2004; 189: 711–6
   PubMed Web of Science ®Google Scholar
• Miller ML, Gao G, Pestina T, Persons D, Tuomanen E. Hypersusceptibility to invasive pneumococcal infection in experimental sickle cell disease involves platelet-activating factor receptor. J Infect Dis 2007; 195: 581–4
   PubMed Web of Science ®Google Scholar
• Fillon S, Soulis K, Rajasekaran S, Edict-Hamilton H, Radin JN, Orihuela CJ, et al. Platelet-activating factor receptor and innate immunity: uptake of Gram-positive bacterial cell wall into host cells and cell-specific pathophysiology. J Immunol 2006; 177: 6182–91
   PubMed Web of Science ®Google Scholar
• Orihuela CJ, Fillon S, Smith-Sielicki SH, El Kasmi KC, Gao G, Soulis K, et al. Cell wall-mediated neuronal damage in early sepsis. Infect Immun 2006; 74: 3783–9
   PubMed Web of Science ®Google Scholar
• Avadhanula V, Rodriguez CA, DeVincenzo JP, Wang Y, Webby RJ, Ulett GC, et al. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol 2006; 80: 1629–36
   PubMed Web of Science ®Google Scholar
• van der Sluijs KF, van Elden LJ, Nijhuis M, Schuurman R, Florquin S, Shimizu T, et al. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during post influenza pneumonia. Am J Physiol Lung Cell Mol Physiol 2006; 290: 194–9
   PubMed Web of Science ®Google Scholar
• Orihuela CJ, Gao G, McGee M, Yu J, Francis KP, Tuomanen E. Organ-specific models of Streptococcus pneumoniae disease. Scand J Infect Dis 2003; 35: 647–52
   PubMed Web of Science ®Google Scholar
• Branger J, Wieland CW, Florquin S, Maris NA, Pater JM, Speelman P, et al. Platelet-activating factor receptor-deficient mice show an unaltered clearance of non-typeable Haemophilus influenzae from their respiratory tract. Shock 2004; 22: 543–7
   PubMed Web of Science ®Google Scholar
• Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999; 163: 1–5
   PubMed Web of Science ®Google Scholar
• Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A 2003; 100: 1966–71
   PubMed Web of Science ®Google Scholar
• Moreno SE, ves-Filho JC, Rios-Santos F, Silva JS, Ferreira SH, Cunha FQ, et al. Signaling via platelet-activating factor receptors accounts for the impairment of neutrophil migration in polymicrobial sepsis. J Immunol 2006; 177: 1264–71
   PubMed Web of Science ®Google Scholar